
18/09/2025
We’re sure the mainstream media has skewed your view of GLP-1 drugs.
📊 A recent survey (The Hindu, PCRM data) found:
1) Only 18% of urban Indians know GLP-1s reduce appetite — not “burn fat.”
2) Nearly 3 in 4 have only “heard something negative” without real clarity.
3) 81% believe the media exaggerates their effectiveness.
When perception is driven by hype and fear, patients are left without the clarity they deserve.
At Medfin, we believe healthcare conversations must be grounded in evidence and patient-centricity. That’s why our experts emphasize the risk–benefit balance and the importance of personalized guidance — enabling patients to make informed and confident decisions.
📅This Sunday, the 21st of September, at 3PM, Dr. Afshan Shaikh will lead our Medfin Webinar, offering a deeper perspective on GLP-1 medications and what they truly mean for the future of weight management in India.
Be a part of the conversation, Join our WhatsApp Community & get all updates on the Webinar here: https://chat.whatsapp.com/FZCJ8bX5Dtd3puPq3STrjW